| Honeywell Aerospace, Inc. NASDAQ: HONA The complaint alleges that defendants failed to disclose that a small percentage of suppliers had a disproportionate impact on sales and were supply constrained, and that the company was under investigation for potential False Claims Act violations tied to cybersecurity requirements in government contracts. The stock allegedly fell $47.17, or 23.16%, after the August 2026 earnings release with reduced growth guidance, and a further $3.87, or 2.45%, on September 1, 2026 after a Justice Department settlement announcement. |
June 29, 2026 to September 1, 2026 |
November 23, 2026
|
D. Ariz. 2:26-cv-06779 |
Ask about this |
| Tigo Energy, Inc. NASDAQ: TYGO The complaint alleges that Tigo's revenue projections depended on the launch of its EG4 Electronics partnership, which would not provide material revenue until the fourth quarter of 2026 at the earliest, so the projections allegedly lacked a reasonable basis. On August 4, 2026, Tigo cut full-year 2026 revenue guidance from $130 to $135 million to $100 to $110 million, citing the partner's delayed launch, and the stock allegedly fell from $2.04 to $1.29 on August 5. |
February 24, 2026 to August 4, 2026 |
November 23, 2026
|
N.D. Cal. 5:26-cv-10888 |
Ask about this |
| Fluence Energy, Inc. NASDAQ: FLNC The complaint alleges that defendants failed to disclose that Fluence's ability to deliver backlog and recognize fiscal 2026 revenue depended on new contract manufacturing facilities that were not complete or able to produce at the volumes guidance assumed, and that corrective measures were not fixing persistent production problems. The stock allegedly fell 34.63% on February 5, 2026, 7.17% on August 6, 2026, and $1.39, or 15.36%, to $7.66 on September 17, 2026. |
November 24, 2025 to September 16, 2026 |
November 27, 2026 or November 30, 2026
Added by the firm's daily review on September 29, 2026 from the court docket or the statutory notice. Confirm the deadline against the docket before relying on it. The notices differ on the deadline: one states November 30, 2026; another states 60 days from September 28, 2026 (November 27). Both dates are shown. |
E.D. Va. 1:26-cv-08475 |
Ask about this |
| Qfin Holdings, Inc. NASDAQ: QFIN The complaint alleges that Qfin Holdings and certain officers made materially false and misleading statements regarding the resiliency and stability of the company's business and financial results despite regulatory changes affecting China's credit technology sector, and downplayed the severity of the negative impact of regulatory headwinds on the company's business. The complaint alleges that on August 25, 2026, Qfin announced second quarter and interim 2026 unaudited financial results showing net income fell sharply year over year, including an unexpected tax expense, which caused the stock price to decline and damaged investors who purchased during the Class Period. |
March 18, 2026 to August 25, 2026 |
November 27, 2026
|
E.D.N.Y. 26-cv-06024 |
Ask about this |
| Alphabet Inc. NASDAQ: GOOGL The complaint alleges that Alphabet and certain executives failed to disclose that its Gemini 3.5 Pro AI model was delivering disappointing training results and that the model's launch would be significantly delayed, rendering positive statements about the company's AI business materially misleading. The complaint alleges that on July 16, 2026, Bloomberg reported Google was months behind schedule on delivering Gemini 3.5 Pro due to disappointing training results, after which Alphabet's stock price declined sharply. |
May 19, 2026 to July 16, 2026 |
November 30, 2026
|
N.D. Cal. 3:26-cv-11290 |
Ask about this |
| Anavex Life Sciences Corp. NASDAQ: AVXL The complaint alleges that Anavex Life Sciences lacked adequate internal controls and understated potential regulatory challenges arising from misconduct by former CEO Christopher Missling. The complaint alleges that on May 6, 2026 Anavex disclosed Missling's termination for conduct inconsistent with company policy, and later, on August 28, 2026, filed amended annual and quarterly reports disclosing material weaknesses in internal control over financial reporting, with the company's stock falling $0.18 per share, or 5.55%, on May 12, 2026 as related news emerged. |
November 26, 2025 to August 28, 2026 |
November 30, 2026
|
S.D.N.Y. 1:26-cv-08567 |
Ask about this |
| Endava plc NYSE: DAVA The complaint alleges that Endava and certain officers made materially false and misleading statements and failed to disclose that the accounting treatment for certain customer and supplier agreements required additional review, that the company would delay release of its fourth quarter and full year 2026 financial results, and that there was reason to doubt the effectiveness of its internal controls. The complaint alleges the truth emerged after the market closed on September 21, 2026, when Endava announced that its CFO had been placed on administrative leave pending an internal investigation triggered by outside auditors' concerns about the accounting treatment of certain customer and supplier agreements, and that its ADS price fell $0.68 per share, or 24.37%, to close at $2.11 on September 22, 2026. |
September 4, 2025 to September 21, 2026 |
November 30, 2026
|
S.D.N.Y. 1:26-cv-08556 |
Ask about this |
| Coastal Financial Corporation NASDAQ: CCB The complaint alleges that Coastal Financial Corporation and certain officers made materially false and misleading statements about the growth and credit quality of the company's CCBX banking-as-a-service business, the adequacy of its risk management and credit reporting practices, and the credit protections afforded by its CCBX partner indemnification agreements. The complaint alleges that the truth was revealed on July 30, 2026 when Coastal announced second quarter 2026 results showing a surprise GAAP net loss of $42.1 million driven by a $68.8 million credit expense tied to a single CCBX partner relationship, and that on this news the company's stock price fell approximately 43.5%, erasing roughly $470 million in market capitalization. |
October 28, 2024 to July 29, 2026 |
December 1, 2026
|
W.D. Wash. 2:26-cv-03746 |
Ask about this |
| Duolingo, Inc. NASDAQ: DUOL The complaint alleges that Duolingo and certain executives made materially false or misleading statements about daily active user growth, concealing that the company was deliberately adding user friction through increased ad volume and subscription upsells and relying on rapidly produced, lower-quality AI content that was harming the user experience. The complaint alleges the truth emerged through a series of disclosures, including an announcement reversing the monetization push in November 2025 and the February 26, 2026 fourth-quarter results confirming slowed DAU growth and weak 2026 guidance. The complaint alleges that Duolingo shares fell sharply following these disclosures, including a decline of roughly 14% after the February 26, 2026 announcement. |
May 2, 2025 to February 26, 2026 |
December 7, 2026
|
W.D. Pa. 2:26-cv-02197 |
Ask about this |
| Netcapital Inc. NASDAQ: NCPL The complaint alleges that Netcapital and certain officers improperly recognized revenue from sham, backdated and in some instances forged consulting agreements with entities controlled by a company insider, and engaged in undisclosed related-party transactions that inflated reported revenue. The complaint alleges that the fraud was revealed when the SEC filed an enforcement complaint against Netcapital and individual defendants on August 10, 2026 alleging the same scheme, after which the company's auditor withdrew. |
December 15, 2021 to September 3, 2026 |
December 7, 2026
|
D. Mass. 1:26-cv-14584 |
Ask about this |
| The Chemours Company NYSE: CC The complaint alleges that Chemours and certain executives made materially false and misleading statements about aftermarket demand for its Opteon refrigerant products and the reliability of its fiscal 2026 financial guidance. The complaint alleges that Chemours overstated aftermarket demand for Opteon products sold through its Thermal & Specialized Solutions segment despite an oversupplied channel heading into 2026. The complaint alleges that when the guidance cut and channel oversupply were disclosed on August 4-5, 2026, Chemours stock fell $3.34 per share, or about 18.6%, to close at $14.59 per share. |
February 20, 2026 to August 4, 2026 |
December 7, 2026
|
D. Del. 1:26-cv-01299 |
Ask about this |
| The Ensign Group, Inc. NASDAQ: ENSG The complaint alleges that Ensign and certain executives made materially false and misleading statements about the company's skilled nursing facility operations, including that Ensign's business model and profitability depended on systematic understaffing and neglect of residents, that self-reporting compliance measures concealed these practices, and that the company engaged in an improper scheme of renting administrator licenses to create a false appearance of regulatory compliance at its facilities. The complaint alleges the truth emerged through a series of short-seller reports beginning June 8, 2026 (Hunterbrook Media) and continuing through a June 18, 2026 follow-up report, which were followed by declines in Ensign's stock price. Investors who purchased Ensign securities during the class period allege they suffered losses as the stock fell from prior highs following these disclosures. |
February 10, 2022 to June 18, 2026 |
December 7, 2026
|
C.D. Cal. 8:26-cv-02963 |
Ask about this |
| Webull Corporation NASDAQ: BULL The complaint alleges that Webull overstated its independence from mainland China, including claims that its primary operations were U.S.-based and that U.S. customer data was protected from non-U.S. access, while its software development, data pipelines, and core engineering allegedly depended on PRC-based personnel and infrastructure. The complaint alleges that on October 7, 2026, CNBC reported findings from the House Select Committee on China detailing extensive ties between Webull and China, after which Webull shares fell approximately 19% to close at $5.89. |
April 26, 2025 to October 6, 2026 |
December 7, 2026
|
M.D. Fla. 8:26-cv-03052 |
Ask about this |
| Compass, Inc. NYSE: COMP The complaint alleges that the offering materials issued in connection with Compass's January 9, 2026 stock-for-stock merger with Anywhere Real Estate misrepresented and omitted material information concerning defendants' attestations to use reasonable best efforts to obtain required regulatory authorizations and consents, as well as their compliance with applicable laws and the absence of governmental investigations. The complaint further alleges, according to related reporting, that Compass sought to use an attorney connected to the prior administration as an improper back-channel to expedite Department of Justice review of the merger. The suit is brought on behalf of former Anywhere shareholders who received newly issued Compass common stock in the merger exchange. |
See case description |
December 8, 2026
|
S.D.N.Y. 1:26-cv-08885 |
Ask about this |
| Millrose Properties, Inc. NYSE: MRP The complaint alleges that Millrose and certain executives made false and misleading statements that the company's business was limited to land purchases, horizontal development, and homesite option purchase arrangements for Lennar and other homebuilders, and would not involve entering into lease agreements. The complaint alleges that an October 2, 2026 report revealed Millrose had purchased an estimated $200 million of finished homes from its former parent Lennar and was renting them out, reportedly at a loss. The complaint alleges that on this news Millrose shares fell roughly 8.5%, or about $2.10 per share. |
February 7, 2025 to October 2, 2026 |
December 8, 2026
|
S.D. Fla. 9:26-cv-81386 |
Ask about this |
| Gildan Activewear Inc. NYSE: GIL The complaint alleges that Gildan and certain executives made false and/or misleading statements and failed to disclose that the company lacked adequate internal controls and used channel stuffing to create an appearance of revenue growth. The complaint alleges the truth began to emerge on June 16, 2026 when a short seller report accused Gildan of pushing excess product into its distribution channel beyond underlying demand, after which Gildan shares fell approximately 18.7 percent in a single trading session. The complaint alleges that as a result, defendants' prior statements about Gildan's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. |
February 19, 2025 to June 15, 2026 |
December 14, 2026
|
N.D.N.Y. 1:26-cv-02126 |
Ask about this |
| Triller Group Inc. (formerly AGBA Group Holding Limited) NASDAQ: ILLR The complaint alleges that Triller and certain executives made false and misleading statements and failed to disclose that the company's control over and consolidation of the Bare Knuckle Fighting Championship business was tenuous or overstated, and that Triller could not timely file required periodic financial reports with the SEC, increasing the risk of Nasdaq delisting. The complaint alleges that these disclosure failures led to a suspension of trading in Triller's securities that was not lifted until April 2026, causing investor losses. |
October 16, 2024 to December 29, 2025 |
December 14, 2026
|
C.D. Cal. 26-cv-11989 |
Ask about this |
| Bank of America Corporation NYSE: BAC The complaint alleges that Bank of America and certain executives misrepresented the scope and severity of deficiencies in its Bank Secrecy Act/anti-money-laundering compliance program, including claims that a 2024 regulatory consent order covered only limited aspects of its compliance programs and that remediation steps had already been substantially completed. The complaint alleges that defendants knew or recklessly disregarded that systemic BSA/AML weaknesses caused the bank to fail to properly monitor large volumes of transactions and to file inaccurate or incomplete suspicious activity reports. The complaint alleges that the truth emerged through regulatory enforcement actions, including penalties announced by FinCEN, the OCC, and OFAC, and that Bank of America shares fell to an intraday low before closing down 4.8 percent on October 14, 2026. |
August 1, 2025 to October 13, 2026 |
December 15, 2026
|
S.D.N.Y. 1:26-cv-09137 |
Ask about this |
| D-Wave Quantum Inc. NASDAQ: QBTS The complaint alleges that D-Wave and certain of its executives made false and/or misleading statements that materially overstated the company's business, operational, and financial prospects, including in connection with a purported partnership tied to a customer referred to as DarkNX/Accelsius-type disclosures. The complaint alleges the truth began to emerge on August 6, 2026, when D-Wave reported second quarter 2026 revenue of about $3.08 million, missing analyst expectations, causing the stock to fall; the complaint further alleges an additional corrective disclosure on August 25, 2026, when the company announced its CFO's resignation. |
February 26, 2026 to August 25, 2026 |
December 15, 2026
|
N.D. Cal. 5:26-cv-11953 |
Ask about this |
| Skechers U.S.A., Inc. NYSE: SKX The complaint alleges that Skechers executives and directors, together with 3G Capital Partners and financial adviser Greenhill & Co., misrepresented the fairness of the $63-per-share take-private acquisition by repeatedly lowering the company's internal financial projections after 3G Capital had already locked in its offer price and by privately assuring 3G Capital that tariffs would have minimal impact on future growth while that assessment was not disclosed to public shareholders. The complaint alleges that these alleged omissions caused shareholders who sold their Class A stock between April 24, 2025 and September 12, 2025, including in the take-private transaction, to receive artificially deflated consideration for their shares. The case was first filed on October 21, 2026 in the United States District Court for the Central District of California. |
April 24, 2025 to September 12, 2025 |
December 21, 2026
|
C.D. Cal. 2:26-cv-12327 |
Ask about this |
| Everest Group, Ltd. NYSE: EG The complaint alleges that Everest and certain of its executives misrepresented that the company had strengthened its underwriting, adequately priced its policies, reduced exposure to casualty risks subject to social inflation, and maintained sufficient reserves, when in fact Everest remained heavily exposed to escalating U.S. casualty claim costs and had insufficient reserves. The complaint alleges the truth began emerging on October 30, 2024 and January 27, 2025 when Everest disclosed billions in reserve strengthening tied to U.S. casualty losses, and alleges a further corrective disclosure on October 27, 2025 when Everest disclosed approximately $478 million in unfavorable prior-year reserve development, after which the stock fell about 11.4% to close at $304.91 per share on October 28, 2025. |
February 8, 2024 to October 27, 2025 |
December 28, 2026
|
S.D.N.Y. 1:26-cv-09448 |
Ask about this |
| O-I Glass, Inc. NYSE: OI The complaint alleges that O-I Glass and certain executives made materially false and misleading statements about the progress of the company's 'Fit to Win' cost-savings program, concealing delays in achieving targeted cost savings, higher than expected expenses, and operational disruptions that offset the program's benefits. The complaint alleges the truth emerged on July 28, 2026 when the company announced second quarter results that substantially reduced its 2026 adjusted EBITDA and free cash flow guidance and realigned its 2027 Investor Day targets, after which the stock price fell from a closing price of $9.06 to $7.70 per share, a decline of about 15%. |
March 14, 2025 to July 28, 2026 |
December 28, 2026
|
N.D. Ohio 3:26-cv-02849 |
Ask about this |
| Tenax Therapeutics, Inc. NASDAQ: TENX The complaint alleges that Tenax and certain executives made false and misleading statements overstating the likelihood that its lead drug candidate TNX-103 (oral levosimendan) would succeed in the Phase 3 LEVEL trial for pulmonary hypertension with heart failure with preserved ejection fraction, and that the company's 'derisked' development narrative lacked adequate basis. The complaint alleges the truth emerged on August 10, 2026 when Tenax announced that the LEVEL trial failed to meet its primary endpoint (six-minute walk distance) and key secondary endpoint versus placebo, after which the stock price fell roughly 84 percent. |
November 13, 2023 to August 7, 2026 |
December 28, 2026
|
M.D.N.C. 1:26-cv-01264 |
Ask about this |
| UP Fintech Holding Limited NASDAQ: TIGR The complaint alleges that UP Fintech materially understated its legal and regulatory risk given continued operations in mainland China, making the company's statements about its business, operations, and prospects materially false and misleading. The complaint alleges the relevant disclosure came on May 22, 2026, when UP Fintech disclosed that its Tiger Brokers subsidiary was under investigation by the China Securities Regulatory Commission for unlicensed cross-border securities business, an investigation that also implicated industry peers, exposing the company to potential administrative penalties and confiscation of alleged illegal income. |
April 22, 2024 to June 2, 2026 |
December 28, 2026
|
D.N.J. 2:26-cv-13939 |
Ask about this |
| Yiren Digital Ltd. NYSE: YRD The complaint alleges that Yiren Digital Ltd. and certain of its officers made materially false and/or misleading statements and failed to disclose material adverse facts about the company's business, operations, and prospects during the class period. The complaint alleges that on the corrective disclosure date, Yiren's stock fell sharply, including a reported drop of over 44% on October 13, 2026, as the alleged truth was revealed to the market. The case was filed in the U.S. District Court for the Central District of California with a lead plaintiff deadline of December 28, 2026. |
April 29, 2026 to October 13, 2026 |
December 28, 2026
|
C.D. Cal. 2:26-cv-12673 |
Ask about this |
| lululemon athletica inc. NASDAQ: LULU The complaint alleges that lululemon and certain executives failed to disclose that store traffic and product demand were significantly deteriorating due to negative media and social media commentary and underwhelming new product launches, and that this rendered the company's previously issued FY2026 financial guidance unrealistic. The complaint alleges that on September 3, 2026, lululemon announced weaker than expected second-quarter fiscal 2026 results and sharply cut its FY2026 revenue and EPS guidance, which caused the stock price to fall materially the next trading day. |
March 18, 2026 to September 3, 2026 |
January 4, 2027
|
D.N.J. 26-cv-14271 |
Ask about this |
| Kinross Gold Corporation NYSE: KGC The complaint alleges that Kinross and certain officers made materially false and misleading statements about the company's production guidance, representing that it could achieve approximately 2 million gold equivalent ounces of production while allegedly concealing that the company lacked the necessary resources to meet that target. The complaint alleges the truth emerged on September 23, 2026, when Kinross issued an operational update reducing its full-year 2026 and 2027 production guidance to approximately 1.84 to 1.86 million gold equivalent ounces, after which the stock price fell from $27.62 to $24.42 per share, a decline of about 11.5%. |
February 18, 2026 to September 23, 2026 |
January 5, 2027
|
D. Colo. 1:26-cv-05910 |
Ask about this |
| Arbor Realty Trust, Inc. NYSE: ABR The complaint alleges that Arbor Realty and certain officers made materially false and misleading statements about the containment of the company's nonperforming and subperforming loans, including claims that such loans were 'ring-fenced' and that the company had clear visibility to resolving nearly all delinquencies by year-end 2026. The complaint alleges that on October 30, 2026, Arbor Realty disclosed third-quarter 2026 results showing a GAAP net loss of $85.4 million, an increase in nonperforming loans from 19 to 32, and the suspension of its quarterly common stock dividend, after which the stock price fell about 29% to close at $2.14 per share. |
February 27, 2026 to October 30, 2026 |
January 8, 2027
|
E.D.N.Y. 1:26-cv-07231 |
Ask about this |
| CVRx, Inc. NASDAQ: CVRX The complaint alleges that CVRx and certain current and former officers made materially false and misleading statements about the company's revenue growth, sales practices, regulatory compliance, reimbursement strategy, and sales-force productivity, and that the company engaged in improper marketing of its Barostim device and other sales practices that exposed it to liability under the False Claims Act and Anti-Kickback Statute. The complaint alleges that following disclosure of a Department of Justice civil investigative demand, cuts to revenue guidance, sales-force disruption, and the termination of its Chief Revenue Officer, CVRx's stock price fell about 60%, from $5.94 to $2.39 per share. |
July 25, 2023 to August 6, 2026 |
January 8, 2027
|
D. Minn. 26-cv-4746 |
Ask about this |
| NVIDIA Corporation NASDAQ: NVDA The complaint alleges that NVIDIA and CEO Jensen Huang made materially false or misleading statements by describing the company's dealings with Megaspeed as routine while failing to disclose Huang's personal relationship with a former Megaspeed executive suspected of ties to Chinese intelligence. The complaint alleges that when this relationship and related risks came to light, NVIDIA shares fell approximately 4.27% to close at $178.67 on November 9, 2026, causing losses to investors who purchased shares during the proposed class period. |
October 9, 2025 to November 8, 2026 |
January 8, 2027
|
N.D. Cal. 5:26-cv-13448 |
Ask about this |
| Lennar Corporation NYSE: LEN The complaint alleges that Lennar and certain top executives made materially false and misleading statements about the company's land-light operating strategy and the purpose of its spin-off of Millrose Properties, including allegedly concealing that Lennar was capitalizing costs associated with land-bank option agreements to present a more favorable picture of performance. The complaint alleges that on December 16, 2025 Lennar reported disappointing fourth-quarter and full-year 2025 results with adjusted earnings per share far below the prior year and analyst expectations, and that on October 2, 2026 a short-seller report alleged Lennar was using the Millrose spin-off to prop up home sales contrary to its stated purpose, after which Lennar's stock price is alleged to have fallen on both occasions. |
February 7, 2025 to October 2, 2026 |
January 11, 2027
|
S.D. Fla. 26-cv-28015 |
Ask about this |
| NuScale Power Corporation NYSE: SMR The complaint alleges that NuScale overstated its commercial prospects during the class period, including its purported status as the nuclear small-modular-reactor industry's 'first mover,' its ability to generate revenue from the RoPower Project and work for the Tennessee Valley Authority, and the resulting strength of its remaining cash runway. The complaint alleges that when the truth about these matters was revealed, NuScale's stock price declined, injuring investors who purchased shares during the class period. |
February 27, 2026 to September 10, 2026 |
January 11, 2027
|
D. Or. 26-cv-02483 |
Ask about this |
| Portillo's Inc. NASDAQ: PTLO The complaint alleges that Portillo's and certain officers failed to disclose that the company had expanded too quickly into markets with insufficient consumer awareness and demand, placed new restaurants too close to existing locations, and cannibalized sales, resulting in dead-site and strategic-reset costs that were not disclosed to investors. The complaint alleges that a series of partial disclosures between August 2025 and May 2026 revealed these issues, and that on the news the stock fell from $5.72 to $4.79 per share (a 16.3% drop) and continued declining to $3.93 per share by May 18, 2026, a cumulative drop of about 31.2%. |
September 19, 2023 to May 4, 2026 |
January 11, 2027
|
N.D. Ill. |
Ask about this |
| Intel Corporation NASDAQ: INTC The complaint alleges that Intel and executives Lip-Bu Tan and David Zinsner misled investors about the severity of a PC sales slowdown hitting the Client Computing and Physical AI Group, concealed a glut of unsold PC inventory held by partners, and did not disclose that substrate supply constraints were limiting Intel's ability to meet data center chip demand. The complaint alleges that after Intel reported third-quarter 2026 results on October 29, 2026 showing declining segment revenue and fourth-quarter guidance roughly $1.5 billion below analyst estimates, Intel's stock price fell nearly 30% the next trading day. |
July 23, 2026 to October 29, 2026 |
January 12, 2027
|
N.D. Cal. 5:26-cv-13758 |
Ask about this |
| Fervo Energy Company NASDAQ: FRVO The complaint alleges that Fervo's registration statement and prospectus for its May 2026 IPO failed to disclose that the company's pilot plant was experiencing inconsistent production temperatures and premature thermal decline, that its enhanced geothermal operations were losing injected water at levels above what its commercial plans required, that its drilling costs were not declining as represented, and that it lacked sufficient transmission capacity. The complaint alleges that by the time the action was filed, Fervo's stock had closed as low as $7.79 per share, more than a 71% decline from the $27 per share IPO price. |
May 13, 2026 to May 13, 2026 |
January 18, 2027
|
S.D. Tex. 4:26-cv-10141 |
Ask about this |
| Build-A-Bear Workshop, Inc. NYSE: BBW The complaint alleges that Build-A-Bear Workshop and certain executives made materially false and misleading statements between May 28, 2026 and August 26, 2026 about its fiscal 2026 financial guidance, which allegedly remained overstated even after an earlier guidance cut, and about the strength of its wholesale relationship with Walmart Inc. The complaint alleges that on August 26, 2026, Build-A-Bear disclosed the termination of its Chief Growth Officer and other negative developments, after which the stock price allegedly fell about 27% in a single day. The complaint alleges that investors who purchased shares during the class period suffered losses as a result of the alleged corrective disclosure. |
May 28, 2026 to August 26, 2026 |
January 19, 2027
|
E.D. Mo. |
Ask about this |
| FMC Corporation NYSE: FMC The complaint alleges that FMC Corporation and certain officers made materially false and misleading statements about the company's financial outlook and growth projections while failing to disclose that elevated-priced inventory held by distributors was difficult to sell, impairing replenishment orders and threatening the company's ability to generate new sales, revenue, EBITDA and cash flow. The complaint alleges that FMC's statements about its business, operations, and prospects were materially misleading and/or lacked a reasonable basis, and that investors and analysts reacted negatively when the truth was revealed, with the class period running from February 4, 2026 through October 14, 2026. |
February 4, 2026 to October 14, 2026 |
January 19, 2027
|
E.D. Pa. 2:26-cv-08831 |
Ask about this |